Magnitude of Reduction in PSA Level May Indicate Outcomes in Prostate Cancer
Findings seen for men treated with enzalutamide for nonmetastatic castration-resistant prostate cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.